Screener
Mirum Pharmaceuticals, Inc. MIRM Preferred Stock Par Value Per Share
Preferred Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 1,055,403 | 528,123 |
| Commitments and contingencies | ||
| Stockholders’ (deficit) equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 64,754,699 and 51,896,391 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 6 | 5 |
| Additional paid-in capital | 1,515,172 | 981,878 |
| Accumulated deficit | (1,524,926) | (667,544) |
| Accumulated other comprehensive (loss) income | (674) | 351 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s preferred stock par value per share?
- Mirum Pharmaceuticals, Inc. (MIRM) reported preferred stock par value per share of $0.00 in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s preferred stock par value per share changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s preferred stock par value per share?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does preferred stock par value per share mean?
- The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.
Ask your AI about Mirum Pharmaceuticals, Inc.'s preferred stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude